Stock 2171 CARSGEN THERAPEUTICS HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials CARsgen Therapeutics Holdings Limited

Equities

2171

KYG1996C1006

Biotechnology & Medical Research

Delayed Hong Kong S.E.
Other stock markets
 01:42:31 2024-04-29 am EDT 		5-day change 1st Jan Change
5.69 HKD +4.40% Intraday chart for CARsgen Therapeutics Holdings Limited +25.88% -12.46%
Apr. 12 Carsgen Therapeutics To Give Cancer Drug Oral Presentation at ASCO 2024 MT
Mar. 26 CARsgen Therapeutics Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 12,717 7,576 3,401 2,904 - -
Enterprise Value (EV) 1 10,048 5,427 1,636 1,928 1,914 2,098
P/E ratio -1.83 x -8.17 x -4.41 x -4.19 x -4.02 x -8.84 x
Yield - - - - - -
Capitalization / Revenue 493 x - - 8.79 x 3.24 x 1.07 x
EV / Revenue 389 x - - 5.84 x 2.14 x 0.77 x
EV / EBITDA -19.2 x -7.39 x -2.32 x -2.89 x -2.9 x -8.82 x
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book 4.24 x 3.06 x 1.82 x 2.92 x 7.78 x 24.4 x
Nbr of stocks (in thousands) 567,537 572,625 575,640 575,644 - -
Reference price 2 22.41 13.23 5.908 5.045 5.045 5.045
Announcement Date 3/22/22 3/21/23 3/26/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 25.81 - - 330.3 895.4 2,724
EBITDA 1 -522.7 -734.6 -706 -667.4 -660.9 -237.8
EBIT 1 -575.2 -816.1 -793.3 -709.7 -712.4 -299.9
Operating Margin -2,228.18% - - -214.85% -79.56% -11.01%
Earnings before Tax (EBT) 1 -4,737 -891 -747.4 -680.3 -708 -320.4
Net income 1 -4,744 -892.2 -747.8 -680.3 -708 -320.4
Net margin -18,379.98% - - -205.94% -79.06% -11.77%
EPS 2 -12.26 -1.620 -1.340 -1.204 -1.254 -0.5709
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 - - - - - -
Announcement Date 3/22/22 3/21/23 3/26/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales 1 - 25.81 - - - - 245.3 84.98
EBITDA - - - - - - - -
EBIT 1 -213.2 -361.9 -379.3 -436.8 -385.6 -407.7 -167.5 -419.6
Operating Margin - -1,402.11% - - - - -68.29% -493.8%
Earnings before Tax (EBT) - - - - - - - -
Net income - - - - - - - -
Net margin - - - - - - - -
EPS 2 - 7.420 - -0.9300 -0.7300 -0.6100 -0.2600 -0.7200
Dividend per Share - - - - - - - -
Announcement Date 8/23/21 3/22/22 8/23/22 3/21/23 8/22/23 3/26/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - -
Net Cash position 1 2,669 2,149 1,765 976 990 806
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) -83.1% -31% -35% -58.2% -90.8% -103%
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share 2 5.280 4.320 3.240 1.730 0.6500 0.2100
Cash Flow per Share - - - - - -
Capex 1 178 139 - 218 218 218
Capex / Sales 689.58% - - 66.01% 24.34% 8%
Announcement Date 3/22/22 3/21/23 3/26/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
5.045 CNY
Average target price
6.662 CNY
Spread / Average Target
+32.05%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
CARSGEN THERAPEUTICS HOLDINGS LIMITED Stock CARsgen Therapeutics Holdings Limited
-12.46% 401M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.73B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 2171 Stock
  4. Financials CARsgen Therapeutics Holdings Limited